Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma

Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma

Esophageal cancer is a common malignancy worldwide and a leading cause of cancer-related mortality. Definitive concurrent chemoradiotherapy (CCRT) has been widely used to treat locally advanced esophageal squamous cell carcinoma (ESCC). In this study, we evaluated the predictive power of a 35-gene m...

Full description

Bibliographic Details
Main Authors: Peng Tang, Chen Tan, Qingsong Pang, Chih-Wen Chi, Yuwen Wang, Zhiyong Yuan, Yu-Chuen Huang, Yu-Jen Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
lung radiation dose
concurrent chemoradiotherapy
35-gene panel
squamous cell carcinoma
esophageal cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.729418/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.729418/full

Similar Items